clinical trial · NCT00685815
Intravenous Iron Metabolism in Restless Legs Syndrome
American Regent, Inc.·phase2·completed·n = 12
Restless LegsFerric Carboxymaltose (FCM)Placebo
brief summary
Double-blind, placebo-controlled, entitled: "Intravenous Iron Metabolism in Restless Legs Syndrome
started
Nov 1, 2006
primary completion
Dec 1, 2010
completion
Dec 1, 2012
last updated
May 6, 2025
detailed description
To determine the effects of high-dose infusions of iron on Restless Legs Syndrome (RLS) symptoms and brain concentrations of iron.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol